GILD
Gilead Sciences Inc. Healthcare - Biotechnology Investor Relations →
Gilead Sciences Inc. (GILD) closed at $137.21 as of 2026-03-20, trading 62.7% above its 200-week moving average of $84.34. The stock is currently moving closer to the line, down from 71.8% last week. The 14-week RSI sits at 65, indicating neutral momentum.
Trading volume is running at 1.5x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.14 ratio) is neutral — neither side is clearly dominating.
Over the past 1734 weeks of data, GILD has crossed below its 200-week moving average 16 times. On average, these episodes lasted 26 weeks. Historically, investors who bought GILD at the start of these episodes saw an average one-year return of +15.6%.
With a market cap of $170.3 billion, GILD is a large-cap stock. The company generates a free cash flow yield of 4.4%. Return on equity stands at 40.7%, indicating strong profitability. The stock trades at 7.5x book value.
Over the past 33.2 years, a hypothetical investment of $100 in GILD would have grown to $36845, compared to $2683 for the S&P 500. That represents an annualized return of 19.4% vs 10.4% for the index — confirming GILD as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: GILD vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After GILD Crosses Below the Line?
Across 16 historical episodes, buying GILD when it crossed below its 200-week moving average produced an average return of +13.6% after 12 months (median +5.0%), compared to +11.0% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +40.1% vs +25.9% for the index.
Each line shows $100 invested at the moment GILD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
GILD has crossed below its 200-week MA 16 times with an average 1-year return of +15.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 1993 | Apr 1993 | 9 | 17.5% | -2.1% | +53991.3% |
| Jul 1993 | Aug 1993 | 2 | 3.5% | -35.5% | +46123.5% |
| Aug 1993 | Aug 1993 | 1 | 1.9% | -21.4% | +45298.1% |
| Sep 1993 | Sep 1993 | 1 | 0.5% | -24.6% | +44501.6% |
| Oct 1993 | Jan 1995 | 65 | 44.9% | -32.5% | +44501.6% |
| Jun 1998 | Oct 1998 | 16 | 29.8% | +111.8% | +24947.2% |
| Apr 2010 | Jan 2012 | 90 | 26.8% | -6.3% | +853.3% |
| Jul 2016 | Feb 2020 | 186 | 24.4% | -1.7% | +144.4% |
| Aug 2020 | Jan 2021 | 22 | 12.2% | +13.8% | +156.9% |
| Feb 2021 | Mar 2021 | 5 | 5.9% | -1.1% | +159.7% |
| Apr 2021 | May 2021 | 1 | 2.1% | -2.4% | +160.5% |
| Feb 2022 | May 2022 | 14 | 8.3% | +46.1% | +158.3% |
| Jun 2022 | Jun 2022 | 2 | 6.2% | +34.1% | +160.7% |
| Jul 2022 | Aug 2022 | 3 | 2.9% | +37.9% | +157.2% |
| Apr 2024 | May 2024 | 2 | 1.5% | +63.6% | +123.4% |
| May 2024 | Jun 2024 | 4 | 2.3% | +69.6% | +122.5% |
| Average | 26 | — | +15.6% | — |
Frequently Asked Questions
Is GILD below its 200-week moving average?
No. Gilead Sciences Inc. (GILD) is currently 62.7% above its 200-week moving average of $84.34. It would need to fall to $84.34 to cross below the line.
What is GILD's 200-week moving average price?
Gilead Sciences Inc.'s 200-week moving average is $84.34 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when GILD drops below its 200-week moving average?
GILD has crossed below its 200-week moving average 16 times in our data. On average, buying at that moment produced a one-year return of +15.6%. These dips have historically been decent entry points. These episodes lasted 26 weeks on average.
Is GILD a good value right now?
Here's what our data says about GILD as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 65. Free cash flow yield is 4.4%. Return on equity is 40.7%. Price-to-book is 7.5x. This is not a buy or sell recommendation — always do your own research.
How does GILD compare to the S&P 500?
Over the past 33.2 years, $100 invested in GILD would have grown to $36845, compared to $2683 for the S&P 500. That's 19.4% annualized vs 10.4% for the index. GILD has outperformed the broader market over this period.
Does GILD pay a dividend?
Yes. Gilead Sciences Inc. currently pays a dividend yield of 239.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20